Resting of cryopreserved PBMC does not generally benefit the performance of antigen-specific T Cell ELISPOT assays

Cells

Volumn 1, Issue 3, 2012, Pages 409-427

  Kuerten, Stefanie ^a   Batoulis, Helena ^a   Recks, Mascha S ^a   Karacsony, Edith ^b   Zhang, Wenji ^b   Subbramanian, Ramu A ^b   Lehmann, Paul V ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Cellular Technology Limited (CTL)   (United States)

Author keywords

CEF; Cryopreservation; High throughput; Mumps; T cells

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; HUMAN INTERFERON; MUMPS SKIN TEST ANTIGEN;

APOPTOSIS; ARTICLE; BLOOD STORAGE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOPRESERVATION; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PARAMETERS; PERFORMANCE; PERIPHERAL BLOOD MONONUCLEAR CELL; STIMULATION; T LYMPHOCYTE; THAWING; WILCOXON SIGNED RANKS TEST;

EID: 84870625724     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells1030409     Document Type: Article

References (43)

1. Basha, S.; Hazenfeld, S.; Brady, R.C.; Subbramanian, R.A. Comparison of antibody and T-cell responses elicited by licensed inactivated-and live-attenuated influenza vaccines against H3N2 hemagglutinin. Hum. Immunol. 2011, 72, 463-469.
2. Emery, S.; Workman, C.; Puls, R.L.; Bloch, M.; Baker, D.; Bodsworth, N.; Anderson, J.; Crowe, S.M.; French, M.A.; Hoy, J.; et al. Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjects. Hum. Vaccin. 2005, 1, 232-238.
3. Huang, J.; Ma, R.; Wu, C.Y. Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses. Vaccine 2006, 24, 4905-4913.
4. Heeger, P.S.; Forsthuber, T.; Shive, C.; Biekert, E.; Genain, C.; Hofstetter, H.H.; Karulin, A.; Lehmann, P.V. Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant. J. Immunol. 2000, 164, 5771-5781.
5. Hetherington, V.J.; Kawalec, J.S.; Dockery, D.S.; Targoni, O.S.; Lehmann, P.V.; Nadler, D. Immunologic testing of xeno-derived osteochondral grafts using peripheral blood mononuclear cells from healthy human donors. BMC Musculoskelet. Disord. 2005, 6, 36.
6. Rozieres, A.; Hennino, A.; Rodet, K.; Gutowski, M.C.; Gunera-Saad, N.; Berard, F.; Cozon, G.; Bienvenu, J.; Nicolas, J.F. Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 2009, 64, 534-542.
7. Hofstetter, H.H.; Targoni, O.S.; Karulin, A.Y.; Forsthuber, T.G.; Tary-Lehmann, M.; Lehmann, P.V. Does the frequency and avidity spectrum of the neuroantigen-specific T cells in the blood mirror the autoimmune process in the central nervous system of mice undergoing experimental allergic encephalomyelitis? J. Immunol. 2005, 174, 4598-4605.
8. Schloot, N.C.; Meierhoff, G.; Karlsson Faresjo, M.; Ott, P.; Putnam, A.; Lehmann, P.; Gottlieb, P.; Roep, B.O.; Peakman, M.; Tree, T. Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. J. Autoimmun. 2003, 21, 365-376.
9. Tigno-Aranjuez, J.T.; Jaini, R.; Tuohy, V.K.; Lehmann, P.V.; Tary-Lehmann, M. Encephalitogenicity of complete Freund's adjuvant relative to CpG is linked to induction of Th17 cells. J. Immunol. 2009, 183, 5654-5661.
10. Schmittel, A.; Keilholz, U.; Thiel, E.; Scheibenbogen, C. Quantification of tumor-specific T lymphocytes with the ELISPOT assay. J. Immunother. 2000, 23, 289-295.
11. Keilholz, U.; Weber, J.; Finke, J.H.; Gabrilovich, D.I.; Kast, W.M.; Disis, M.L.; Kirkwood, J.M.; Scheibenbogen, C.; Schlom, J.; Maino, V.C.; et al. Immunologic monitoring of cancer vaccine therapy: Results of a workshop sponsored by the Society for Biological Therapy. J. Immunother. 2002, 25, 97-138.
12. Whiteside, T.L. Immunologic monitoring of clinical trials in patients with cancer: Technology versus common sense. Immunol. Invest. 2000, 29, 149-162.
13. Lehmann, P.V.; Zhang, W. Unique strengths of ELISPOT for T cell diagnostics. Methods Mol. Biol. 2012, 792, 3-23.
14. Helms, T.; Boehm, B.O.; Asaad, R.J.; Trezza, R.P.; Lehmann, P.V.; Tary-Lehmann, M. Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients. J. Immunol. 2000, 164, 3723-3732.
15. Kreher, C.R.; Dittrich, M.T.; Guerkov, R.; Boehm, B.O.; Tary-Lehmann, M. CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. J. Immunol. Methods 2003, 278, 79-93.
16. Quast, S.; Zhang, W.; Shive, C.; Kovalovski, D.; Ott, P.A.; Herzog, B.A.; Boehm, B.O.; Tary-Lehmann, M.; Karulin, A.Y.; Lehmann, P.V. IL-2 absorption affects IFN-gamma and IL-5, but not IL-4 producing memory T cells in double color cytokine ELISPOT assays. Cell Immunol. 2005, 237, 28-36.
17. Hofstetter, H.H.; Toyka, K.V.; Tary-Lehmann, M.; Lehmann, P.V. Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. J. Immunol. 2007, 178, 1372-1378.
18. Nowacki, T.M.; Kuerten, S.; Zhang, W.; Shive, C.L.; Kreher, C.R.; Boehm, B.O.; Lehmann, P.V.; Tary-Lehmann, M. Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells. Cell Immunol. 2007, 247, 36-48.
19. Rininsland, F.H.; Helms, T.; Asaad, R.J.; Boehm, B.O.; Tary-Lehmann, M. Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity. J. Immunol. Methods 2000, 240, 143-155.
20. Kuerten, S.; Nowacki, T.M.; Kleen, T.O.; Asaad, R.J.; Lehmann, P.V.; Tary-Lehmann, M. Dissociated production of perforin, granzyme B, and IFN-gamma by HIV-specific CD8(+) cells in HIV infection. AIDS Res. Hum. Retroviruses 2008, 24, 62-71.
21. Guerkov, R.E.; Targoni, O.S.; Kreher, C.R.; Boehm, B.O.; Herrera, M.T.; Tary-Lehmann, M.; Lehmann, P.V.; Schwander, S.K. Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: Cognate vs. nonspecific production of the cytokine. J. Immunol. Methods 2003, 279, 111-121.
22. Karulin, A.Y.; Hesse, M.D.; Tary-Lehmann, M.; Lehmann, P.V. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity. J. Immunol. 2000, 164, 1862-1872.
23. Tary-Lehmann, M.; Hamm, C.D.; Lehmann, P.V. Validating reference samples for comparison in a regulated ELISPOT assay. In Validation of Cell-Based Assays in the GLP Setting; Prabhakar, U., Kelley, M., Eds.; Wiley: Weinheim, Germany, 2008.
24. Malyguine, A.; Strobl, S.L.; Shafer-Weaver, K.A.; Ulderich, T.; Troke, A.; Baseler, M.; Kwak, L.W.; Neelapu, S.S. A modified human ELISPOT assay to detect specific responses to primary tumor cell targets. J. Transl. Med. 2004, 2, 9.
25. Janetzki, S.; Panageas, K.S.; Ben-Porat, L.; Boyer, J.; Britten, C.M.; Clay, T.M.; Kalos, M.; Maecker, H.T.; Romero, P.; Yuan, J.; et al. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunol. Immunother. 2008, 57, 303-315.
26. Britten, C.M.; Gouttefangeas, C.; Welters, M.J.; Pawelec, G.; Koch, S.; Ottensmeier, C.; Mander, A.; Walter, S.; Paschen, A.; Muller-Berghaus, J.; et al. The CIMT-monitoring panel: A two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol. Immunother. 2008, 57, 289-302.
27. Janetzki, S.; Cox, J.H.; Oden, N.; Ferrari, G. Standardization and validation issues of the ELISPOT assay. Methods Mol. Biol. 2005, 302, 51-86.
28. Gill, D.K.; Huang, Y.; Levine, G.L.; Sambor, A.; Carter, D.K.; Sato, A.; Kopycinski, J.; Hayes, P.; Hahn, B.; Birungi, J.; et al. Equivalence of ELISpot assays demonstrated between major HIV network laboratories. PLoS One 2010, 5, e14330.
29. Almeida, C.A.; Roberts, S.G.; Laird, R.; McKinnon, E.; Ahmed, I.; Pfafferott, K.; Turley, J.; Keane, N.M.; Lucas, A.; Rushton, B.; et al. Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses. J. Immunol. Methods 2009, 344, 1-5.
30. Moldovan, I. Cellular Technology Limited, Shaker Heights, OH, USA. Personal communication, 2012.
31. Cellular Technology Limited (CTL). ePBMC data base. Available online: http://www.immunospot.com (accessed on 23 July 2012).
32. Kierstead, L.S.; Dubey, S.; Meyer, B.; Tobery, T.W.; Mogg, R.; Fernandez, V.R.; Long, R.; Guan, L.; Gaunt, C.; Collins, K.; et al. Enhanced rates and magnitude of immune responses detected against an HIV vaccine: Effect of using an optimized process for isolating PBMC. AIDS Res. Hum. Retroviruses 2007, 23, 86-92.
33. Henson, P.M.; Hume, D.A. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol. 2006, 27, 244-250.
34. Fadok, V.A.; Bratton, D.L.; Frasch, S.C.; Warner, M.L.; Henson, P.M. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 1998, 5, 551-562.
35. Voll, R.E.; Herrmann, M.; Roth, E.A.; Stach, C.; Kalden, J.R.; Girkontaite, I. Immunosuppressive effects of apoptotic cells. Nature 1997, 390, 350-351.
36. Bournazou, I.; Pound, J.D.; Duffin, R.; Bournazos, S.; Melville, L.A.; Brown, S.B.; Rossi, A.G.; Gregory, C.D. Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J. Clin. Invest. 2009, 119, 20-32.
37. Haversen, L.; Ohlsson, B.G.; Hahn-Zoric, M.; Hanson, L.A.; Mattsby-Baltzer, I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol. 2002, 220, 83-95.
38. Crouch, S.P.; Slater, K.J.; Fletcher, J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 1992, 80, 235-240.
39. Togawa, J.; Nagase, H.; Tanaka, K.; Inamori, M.; Nakajima, A.; Ueno, N.; Saito, T.; Sekihara, H. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J. Gastroenterol. Hepatol. 2002, 17, 1291-1298.
40. Zimecki, M.; Artym, J.; Chodaczek, G.; Kocieba, M.; Kruzel, M. Effects of lactoferrin on the immune response modified by the immobilization stress. Pharmacol. Rep. 2005, 57, 811-817.
41. Ramachandran, H.; Laux, J.; Moldovan, I.; Caspell, R.; Lehmann, P.V.; Ramachandran, R.A. Optimal thawing of cryopreserved peripheral blood mononuclear cells for use in high-throughput human immune monitoring studies. Cells 2012, 1, 313-324.
42. Lehmann, P.V. Image analysis and data management of ELISPOT assay results. Methods Mol. Biol. 2005, 302, 117-132.
43. FACSDivaTM, version 4; flow cytometry analysis software. BD Biosciences: San Jose, CA, USA.